W. Michael Flanagan insider trades

Open-market stock purchases and sales by W. Michael Flanagan, Unknown at Atrium Therapeutics, Inc, from SEC Form 4 filings since Jan 21, 2021.

Recent trades

DateStockTradeValue
Sep 18, 2026RNA Atrium Therapeutics, IncSold (not open market)$204K
Feb 27, 2026RNA Atrium Therapeutics, IncBought (not open market)—
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)—
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$669K
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$946K
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$2.2M
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$473K
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$894K
Feb 27, 2026RNAM Avidity Biosciences, IncSold (not open market)$1.6M
Jan 21, 2026RNA Avidity Biosciences, IncSold$288K
Jan 21, 2026RNA Avidity Biosciences, IncSold$185K
Jan 7, 2026RNA Avidity Biosciences, IncSold$171K
Dec 17, 2025RNA Avidity Biosciences, IncBought (not open market)—
Dec 17, 2025RNA Avidity Biosciences, IncSold (not open market)$984K

Companies traded

  • RNA Atrium Therapeutics, Inc: 19 sales, last Sep 18, 2026
  • RNAM Avidity Biosciences, Inc: other filings, last Feb 27, 2026

Get free alerts when W. Michael Flanagan files a new trade →